Summary
Plasma and synovial fluid concentrations of diclofenac sodium and its principal hydroxylated metabolites have been measured in sixteen rheumatoid patients on chronic therapy to investigate possible reasons for the drug's extended duration of action despite its apparent short elimination half-life in plasma. Diclofenac was detected in synovial fluid 2 h after dosing but at a lower level than in plasma. Thereafter synovial fluid concentrations remained relatively constant through to 11 h post-dosing whereas plasma levels in the same period declined rapidly from an initially high peak to near the sensitivity limit of the assay. Hydroxylated metabolites (free + conjugated) were rapidly formed with measurable concentrations of the 4′ and 5 mono and dihydroxy derivatives being detected in plasma 2 h after dosing; levels of the 3′ hydroxy metabolite were negligible at this time. Initially plasma levels of all metabolites were higher than those in synovial fluid but after 4 h synovial fluid levels were equal to or slightly higher than those in plasma. The significance of these findings is discussed in relation to the drug's overall clinical effect.
Similar content being viewed by others
References
John VA (1979) The pharmacokinetics and metabolism of diclofenac sodium (Voltarol®) in animals and man. Rheumatol Rehabil 2 [Suppl]: 22–37
Willis JV, Kendall MJ, Jack DB (1981) The influence of food on the absorption of diclofenac after single and multiple oral doses. Eur J Clin Pharmacol 19: 33–37
Kajander A, Martio J (1978) Diclofenac sodium (Voltaren®) and naproxen in the treatment of rheumatoid arthritis: A comparative double-blind study. Scand J Rheumatol 22 [Suppl]: 57–62
Köhler G, Mohing W (1980) Zur Kinetik von Diclofenac-Na in Plasma und Synovialflüssigkeit. Aktuel Rheumatol 5: 151–155
Menasse R, Hedwell PR, Kraetz J, Pericin C, Riesterer L, Sallmann A, Ziel R, Jaques R (1978) Pharmacological properties of diclofenac sodium and its metabolites. Scand J Rheumatol 22 [Suppl]: 5–16
Schneider W, Degen P (1981) Simultaneous determination of diclofenac and its hydroxy metabolites by capillary column gas-chromatography with electron capture detection. J Chromatogr 217: 263–271
Crook PR, Willis JV, Kendall MJ, Jack DB, Fowler PD (1982) The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease. Eur J Clin Pharmacol 21: 331–334
Aylward M, Maddock J, Jones M (1980) Simultaneous pharmacokinetics of anti-rheumatic drugs in plasma and synovial fluids of rheumatoid patients. Abstract 0410, World Congress on Clinical Pharmacology and Therapeutics, London 1980. Turner P, Padgham C (eds) Macmillan Publishers, London Basingstoke
Willis JV, Kendall MJ, Flinn RM, Thornhill DP, Welling PG (1979) The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J Clin Pharmacol 16: 405–410
Wagner J, Sulc M (1979) Binding of diclofenac-Na (Voltaren®) to serum proteins of different species and interactions with other drugs in protein binding. Aktuel Rheumatol 4: 153
Trnavska R, Trnavsky K (1980) Characterisation of salicylate binding to synovial fluid and plasma proteins in patients with rheumatoid arthritis. Eur J Clin Pharmacol 18: 403–406
Farr M, Kendall MJ, Bold AM, Hawkins CF (1981) Significance of pH in synovial fluid. Ann Rheum Dis 40: 621
Willis JV (1982) Factors influencing the pharmacokinetics of diclofenac sodium. Ph D-thesis, University of Birmingham, U.K.
Strusberg A, Meirovich C, Montruli H, Arroyo S, Aguirre J (1981) Action of sodic diclofenac on enzymes, dialines and prostaglandins of synovial fluid in rheumatoid arthritis; Abstract 228. Proceedings of the XVth International Congress of Rheumatology, Paris
Caruso I, Moro E, Patrono C, Sacchetti G, Tamassia V, Tosolini GP (1980) Plasma and synovial fluid pharmacokinetics and prostaglandin inhibitory effects of indoprofen in patients with rheumatoid arthritis. Scand J Rheumatol 9: 123–126
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fowler, P.D., Shadforth, M.F., Crook, P.R. et al. Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis. Eur J Clin Pharmacol 25, 389–394 (1983). https://doi.org/10.1007/BF01037953
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01037953